SETDB1 and cancer: Moreover, a genetic screen of chromatin regulators that modify immunogenicity of mouse cancer models identified derepressed endogenous retroviruses as the predominant targets in Setdb1-deficient cancer cells, with enrichment for peptides from Emv2 envelope glycoprotein, as well as endogenous MLV Gag and polymerase (162).